Aspen agrees terms with Johnson & Johnson for own brand of Covid-19 vaccine

 

Business Day (1 Dec 2021) reported that Aspen Pharmacare has agreed terms for a deal with Covid-19 vaccine manufacturer Johnson & Johnson to produce its own branded version to sell in Africa. The new agreement means Aspen can sell the vaccines it bottles, branded Aspenovax, to AU members and multinational organisations such as the international vaccine-sharing vehicle Covax. It also paves the way for a further licensing deal for manufacturing the active pharmaceutical ingredients used in the vaccine, bolstering Africa’s security of supply. Aspen was contracted by J&J in November 2020 to formulate, fill and package vials of its Covid-19 shot, but until now it has been J&J that determines which countries can purchase the product.

Other news